tiprankstipranks
Trending News
More News >
Contineum Therapeutics, Inc. Class A (CTNM)
:CTNM
US Market
Advertisement

Contineum Therapeutics, Inc. Class A (CTNM) Ownership - Who Owns Contineum Therapeutics, Inc. Class A?

Compare
182 Followers

Contineum Therapeutics, Inc. Class A (CTNM) Ownership Overview

0.86%10.81%40.81%3.51%44.01%
40.81% Other Institutional Investors
3.51% ETFs
44.01% Public Companies and
Individual Investors
The ownership structure of Contineum Therapeutics, Inc. Class A (CTNM) stock is a mix of institutional, retail, and individual investors. Approximately 55.13% of the company’s stock is owned by Institutional Investors, 0.86% is owned by Insiders, and 44.01% is owned by Public Companies and Individual Investors.
The ownership structure of Contineum Therapeutics, Inc. Class A (CTNM) stock is a mix of institutional, retail, and individual investors. Approximately 51.62% of the company’s stock is owned by Institutional Investors, 0.86% is owned by Insiders, and 3.51% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2025
xxxxxxxxxxxxx
$2154233
Jun 30, 2025
xxxxxxxxxxxxx
$2776959

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
718,990Institution3.32%5,823,819
702,311Institution3.25%5,688,719
699,486Institution3.23%5,665,837
572,025Institution2.65%4,633,403
542,628Institution2.51%4,395,287
450,000Institution2.08%3,645,000
312,500Institution1.45%2,531,250
280,000Institution1.29%2,268,000
172,460Insider0.80%1,396,926
117,153Institution0.54%948,939

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
718,990Institution3.32%5,823,819
572,025Institution2.65%4,633,403
450,000Institution2.08%3,645,000
280,000Institution1.29%2,268,000
117,153Institution0.54%948,939
60,305Institution0.28%488,471
57,969Institution0.27%469,549
25,234Institution0.12%204,395
13,307Institution0.06%107,787
11,235Institution0.05%91,004

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
647,624Institution2.99%3,820,982
54,687Institution0.25%322,653
31,672Institution0.15%256,543
25,982Institution0.12%191,747

FAQ

Who Owns Contineum Therapeutics, Inc. Class A (CTNM)?
According to the latest TipRanks data, approximately 40.81% of the company's stock is held by institutional investors, 0.86% is held by insiders, and 44.01% is held by retail investors.
    What percentage of Contineum Therapeutics, Inc. Class A (CTNM) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 40.81% of Contineum Therapeutics, Inc. Class A (CTNM) stock is held by institutional investors.
      What percentage of Contineum Therapeutics, Inc. Class A (CTNM) stock is held by retail investors?
      According to the latest TipRanks data, approximately 44.01% of Contineum Therapeutics, Inc. Class A (CTNM) stock is held by retail investors.
        Who owns the most shares of Contineum Therapeutics, Inc. Class A (CTNM)?
        VANGUARD INDEX FUNDS owns the most shares of Contineum Therapeutics, Inc. Class A (CTNM).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis